[Immunogenetic indicators in protracted hepatitis and their dynamics during the treatment with T-activin].
The authors analyze the course of acute virus hepatitis B in 11 children. Provide results of the treatment with T-activin of K cells in vitro and the clinico-immunologic data on 26 patients afflicted with lingering hepatitis B before and after the treatment with T-activin. Show the hereditary predisposition to an unfavourable course of virus hepatitis B.
Stanevicha
V A
VA
Veksler
Kh M
KhM
D000208:Acute Disease; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D015234:HLA-A Antigens / Q000235:genetics* / Q000276:immunology; D015235:HLA-B Antigens / Q000235:genetics* / Q000276:immunology; D059911:HLA-B18 Antigen; D006509:Hepatitis B / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology; D006801:Humans; D008297:Male; D010455:Peptides / Q000627:therapeutic use*; D011379:Prognosis; D012720:Severity of Illness Index; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D013949:Thymus Extracts / Q000627:therapeutic use*; D013997:Time Factors
D000276:Adjuvants, Immunologic; D015234:HLA-A Antigens; C039682:HLA-A10 antigen; D015235:HLA-B Antigens; C049278:HLA-B16 antigen; D059911:HLA-B18 Antigen; D010455:Peptides; D013949:Thymus Extracts; C036191:T-activin
Immunogeneticheskie pokazateli pri zatiazhnom gepatite i ikh dinamika pri lechenii T-aktivinom.